all AI news
Demis Hassabis, chief of DeepMind spinout Isomorphic Labs, believes the company would halve drug discovery times after inking deals with Eli Lilly and Novartis (Financial Times)
Jan. 10, 2024, 7:35 a.m. |
Techmeme www.techmeme.com
Financial Times:
Demis Hassabis, chief of DeepMind spinout Isomorphic Labs, believes the company would halve drug discovery times after inking deals with Eli Lilly and Novartis — Chief of Google's AI unit and Isomorphic Labs spells out targets following $3bn Eli Lilly-Novartis partnerships
deals deepmind demis demis hassabis discovery drug discovery eli lilly financial google hassabis isomorphic labs labs novartis the company
More from www.techmeme.com / Techmeme
Jobs in AI, ML, Big Data
Software Engineer for AI Training Data (School Specific)
@ G2i Inc | Remote
Software Engineer for AI Training Data (Python)
@ G2i Inc | Remote
Software Engineer for AI Training Data (Tier 2)
@ G2i Inc | Remote
Data Engineer
@ Lemon.io | Remote: Europe, LATAM, Canada, UK, Asia, Oceania
Artificial Intelligence – Bioinformatic Expert
@ University of Texas Medical Branch | Galveston, TX
Lead Developer (AI)
@ Cere Network | San Francisco, US